ID: ALA526288

Max Phase: Preclinical

Molecular Formula: C21H15FO3

Molecular Weight: 334.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc(F)cc1)c1cccc(Oc2cccc(O)c2)c1

Standard InChI:  InChI=1S/C21H15FO3/c22-17-10-7-15(8-11-17)9-12-21(24)16-3-1-5-19(13-16)25-20-6-2-4-18(23)14-20/h1-14,23H/b12-9+

Standard InChI Key:  YRDBOAINVBHTBQ-FMIVXFBMSA-N

Associated Targets(non-human)

Agrobacterium tumefaciens 620 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 334.35Molecular Weight (Monoisotopic): 334.1005AlogP: 5.22#Rotatable Bonds: 5
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.10CX Basic pKa: CX LogP: 5.23CX LogD: 5.22
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.51Np Likeness Score: -0.32

References

1. Ansari FL, Iftikhar F, Ihsan-Ul-Haq, Mirza B, Baseer M, Rashid U..  (2008)  Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepines.,  16  (16): [PMID:18650096] [10.1016/j.bmc.2008.07.009]

Source